COMBO Influenza A+B and COMBO C.d. Toxin A+B rapid tests
COMBO INFLUENZA A+B-CHECK-1 : immunochromatographic rapid test for the qualitative detection of influenza type A and B virus from nasal […]
Compliance with
European regulations
Distribution in
170 + countries
ISO 13485
certified company
POC European
leader
New products
Read more
NT-proBNP quantitative test
Immunochromatographic rapid test for the quantitative determination of amino terminal fragment of the Brain Natriuretic peptide (NT-proBNP) in heparinized plasma […]
COVID-19-CHECK-1 TEST
Immunochromatographic rapid test for the detection of IgM and IgG antibodies to SARS-CoV-2 virus in human whole blood, plasma or […]
Babycheck-1® WB
Home use rapid test for the detection of pregnancy in whole blood (Babycheck-1® WB) Refer to Home use rapid tests […]
STREPA’LERT®
Home use rapid test for the Group A streptococcus in throat infection. This test is now CE marked. Refer to […]
Exhibition
Information notice: MEDLAB DUBAI 2021 EXHIBITION IS POSTPONED
Due to the ongoing COVID-19 pandemic situation, the MEDLAB DUBAI exhibition previously planned from February 8th to 11th, is postponed […]
Information
Syphilis Health Check
The Syphilis Health Check test manufactured by VEDALAB has been granted by FDA on December 15th, 2014 the first-ever CLIA […]
Ebola Rapid Test
VedaLab is very proud to announce that, in collaboration with the CEA (Commissariat à l’Energie Atomique), its very reputable R&D […]
VEDALAB is a privately French owned company, founded in 1991.
It is devoted to the development, production and marketing of in vitro immunodiagnostic rapid tests. As a market leader, VEDALAB focuses on international expansion by forming long-term partnerships with reliable and trustworthy distributors worldwide. Continually expanding its impressive range of products, VEDALAB is today the biggest rapid test manufacturer in Europe.
Learn more